This review highlights recent advances in interventional catheterization and imaging technologies that enable minimally invasive treatment of simple to complex congenital heart disease across all age groups.
Answers are grounded in this paper and cite their sources.
Advances may broaden minimally invasive options for congenital heart disease; leaves open need for prospective outcome trials.
Since 1929, when the first cardiac catheterization was safely performed in a human by Dr. Werner Forssmann (on himself), there has been a rapid progression of cardiac catheterization techniques and technologies. Today, these advances allow us to treat a wide variety of patients with congenital heart disease using minimally invasive techniques; from fetus to infants to adults, and from simple to complex congenital cardiac lesions. In this article, we will explore some of the exciting advances in cardiac catheterization for the treatment of congenital heart disease, including transcatheter valve implantation, hybrid procedures, biodegradable technologies, and magnetic resonance imaging (MRI)-guided catheterization. Additionally, we will discuss innovations in imaging in the catheterization laboratory, including 3D rotational angiography (3DRA), fusion imaging, and 3D printing, which help to make innovative interventional approaches possible.
No takes yet. Share an insight, caveat, or question.
Zampi et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: